sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Other End-user: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare...

Home / Categories / Healthcare
Injectable Drug Delivery Market (Device and Formulations) for Hospitals, Homecare and Other End-user: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021
Injectable Drug Delivery Market (Device...
Report Code
RO1/106/1039

Publish Date
06/Oct/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global injectable drug delivery market, 2015  2021 USD Billion)

2.2. Global injectable drug delivery market : Snapshot

Chapter 3. Injectable Drug Delivery  Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global injectable drug delivery market drivers: Impact analysis

3.2.2. Increasing aging population

3.3. Market restraints


3.3.1. Global injectable drug delivery market restraints: Impact analysis

3.3.2. Possibility of needle infection and injuries

3.4. Opportunities


3.4.1. Increasing demand generic injactable

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by type segment

3.6.2. Market attractiveness analysis, by end-user segment

3.6.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Injectable Drug Delivery Market  Competitive Landscape


4.1. Company market share, 2015 (Subject To Data Availability)


4.1.1. Global injectable drug delivery market: company market share, 2015

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Type and Regional Expansion

4.3. Product Portfolio

Chapter 5. Global Injectable Drug Delivery Market  Type Analysis


5.1. Global injectable drug delivery market: Type overview


5.1.1. Global injectable drug delivery market revenue share, by type, 2015 - 2021

5.2. Device


5.2.1. Global injectable drug delivery market for device, 2015 - 2021 (USD Billion)

5.2.2. Conventional Injection Devices


5.2.2.1. Global injectable drug delivery market for conventional injection devices, 2015 - 2021 (USD Billion)

5.2.3. Self-Injection Devices


5.2.3.1. Global injectable drug delivery market for self-injection devices, 2015 - 2021 (USD Billion)

5.3. Formulations


5.3.1. Global injectable drug delivery market for formulations, 2015 - 2021 (USD Billion)

5.3.2. Conventional Drug Delivery


5.3.2.1. Global injectable drug delivery market for conventional injection devices, 2015 - 2021 (USD Billion)

5.3.3. Novel Drug Delivery


5.3.3.1. Global injectable drug delivery market for novel drug delivery, 2015 - 2021 (USD Billion)

5.3.4. Others


5.3.4.1. Global injectable drug delivery market for other, 2015 - 2021 (USD Billion)


Chapter 6. Global Injectable Drug Delivery Market  End-User Analysis


6.1. Global injectable drug delivery market: End-user overview


6.1.1. Global injectable drug delivery market revenue share, by end-user, 2015 - 2021

6.2. Hospitals


6.2.1. Global injectable drug delivery market for hospitals, 2015 - 2021 (USD Billion)

6.3. Homecare


6.3.1. Global injectable drug delivery market for homecare, 2015 - 2021 (USD Billion)

6.4. Others


6.4.1. Global injectable drug delivery market for others, 2015 - 2021 (USD Billion)

Chapter 7. Global Injectable Drug Delivery Market  Regional Segment Analysis


7.1. Global injectable drug delivery market: Regional overview


7.1.1. Global injectable drug delivery market revenue share, by region, 2015 - 2021

7.2. North America


7.2.1. North America injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.2.2. North America injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.2.3. U.S.


7.2.3.1. U.S. injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.2.3.2. U.S. injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.3. Europe


7.3.1. Europe injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.3.2. Europe injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.3.3. Germany


7.3.3.1. Germany injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion)

7.3.3.2. Germany injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion)

7.3.4. France


7.3.4.1. France injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion)

7.3.4.2. France injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion)

7.3.5. UK


7.3.5.1. UK injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.3.5.2. UK injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific injectable drug delivery market revenue, by type, 2015 - 2021, (USD Billion)

7.4.2. Asia Pacific injectable drug delivery market revenue, by end-user, 2015 - 2021, (USD Billion)

7.4.3. China


7.4.3.1. China injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.4.3.2. China injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.4.4. Japan


7.4.4.1. Japan injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.4.4.2. Japan injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.4.5. India


7.4.5.1. India injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.4.5.2. India injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.5. Latin America


7.5.1. Latin America injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.5.2. Latin America injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.5.3. Brazil


7.5.3.1. Brazil injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.5.3.2. Brazil injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

7.6. Middle East and Africa


7.6.1. Middle East and Africa injectable drug delivery market revenue, by type, 2015 - 2021 (USD Billion)

7.6.2. Middle East and Africa injectable drug delivery market revenue, by end-user, 2015 - 2021 (USD Billion)

Chapter 8. Company Profile


8.1. Pfizer, Inc.


8.1.1. Overview

8.1.2. Financials

8.1.3. Product portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. Baxter International Inc.


8.2.1. Overview

8.2.2. Financials

8.2.3. Product portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. Terumo Corporation


8.3.1. Overview

8.3.2. Financials

8.3.3. Product portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. Becton, Dickinson and Company


8.4.1. Overview

8.4.2. Financials

8.4.3. Product portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. Schott AG


8.5.1. Overview

8.5.2. Financials

8.5.3. Product portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Sandoz


8.6.1. Overview

8.6.2. Financials

8.6.3. Product portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. Gerresheimer AG


8.7.1. Overview

8.7.2. Financials

8.7.3. Product portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. Baxter International, Inc.


8.8.1. Overview

8.8.2. Financials

8.8.3. Product portfolio

8.8.4. Business strategy

8.8.5. Recent developments

8.9. Alkermes PLC


8.9.1. Overview

8.9.2. Financials

8.9.3. Product portfolio

8.9.4. Business strategy

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com